A common antigenic motif recognized by naturally occurring human VH5-51/VL4-1 anti-tau antibodies with distinct functionalities.
Apetri, A., Crespo, R., Juraszek, J., Pascual, G., Janson, R., Zhu, X., Zhang, H., Keogh, E., Holland, T., Wadia, J., Verveen, H., Siregar, B., Mrosek, M., Taggenbrock, R., Ameijde, J., Inganas, H., van Winsen, M., Koldijk, M.H., Zuijdgeest, D., Borgers, M., Dockx, K., Stoop, E.J.M., Yu, W., Brinkman-van der Linden, E.C., Ummenthum, K., van Kolen, K., Mercken, M., Steinbacher, S., de Marco, D., Hoozemans, J.J., Wilson, I.A., Koudstaal, W., Goudsmit, J.(2018) Acta Neuropathol Commun 6: 43-43
- PubMed: 29855358 
- DOI: 10.1186/s40478-018-0543-z
- Primary Citation of Related Structures:  
5ZV3, 6DCV, 6DCW, 6GK7, 6GK8 - PubMed Abstract: 
Misfolding and aggregation of tau protein are closely associated with the onset and progression of Alzheimer's Disease (AD). By interrogating IgG + memory B cells from asymptomatic donors with tau peptides, we have identified two somatically mutated V H 5-51/V L 4-1 antibodies ...